ATEM, NCT05416476: Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine |
|
|
| Recruiting | 3 | 288 | RoW | Anisodine Hydrobromide, Anisodine Hydrobromide placebo | Second Affiliated Hospital, School of Medicine, Zhejiang University | Migraine Without Aura, Migraine With Aura | 10/25 | 12/25 | | |
METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery with or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases from Non-small Cell Lung Cancer (NSCLC). |
|
|
| Completed | 3 | 298 | Europe, Canada, US, RoW | NovoTTF-200M device, Best Standard of Care | NovoCure GmbH | Brain Metastases from Non-small Cell Lung Cancer (NSCLC) | 11/24 | 11/24 | | |
NCT05892354: Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy |
|
|
| Recruiting | N/A | 190 | RoW | Enteral immunonutrition, Standard enteral nutrition | First Affiliated Hospital of Guangxi Medical University, Guangdong Provincial People's Hospital, Zhejiang Cancer Hospital, Zhejiang Provincial People's Hospital, Fujian Cancer Hospital, Fujian Provincial Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, The First Affiliated Hospital of Nanchang University, Second Affiliated Hospital of Nanchang University, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Qingdao Central Hospital, Huizhou Municipal Central Hospital, Haikou People's Hospital, The Second Affiliated Hospital of Hainan Medical University, Zhejiang Provincial Tongde Hospital, Guilin Medical University, China, Liuzhou Workers Hospital, Wuzhou Red Cross Hospital, Red Cross Hospital of Yulin City, First People's Hospital of Yulin, Hainan Cancer Hospital | Locally Advanced Nasopharyngeal Carcinoma | 04/25 | 04/27 | | |
NCT06753890: Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern) |
|
|
| Not yet recruiting | 3 | 520 | RoW | Changkang granules, Changkang Granules placebo | Tasly Pharmaceutical Group Co., Ltd | Diarrhea-predominant Irritable Boewl Syndrome | 11/26 | 12/26 | | |
